Vanita Noronha

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 415 citations

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Vanita Noronha, Amit Joshi, Vijay Patil et al. · Journal of Clinical Oncology · 2017 · 326 citations

Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Vedang Murthy, Priyamvada Maitre, Sadhana Kannan et al. · Journal of Clinical Oncology · 2021 · 308 citations

Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience

Kumar Prabhash, Vanita Noronha, Rajesh Dikshit et al. · Indian Journal of Cancer · 2012 · 183 citations

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

Vijay Patil, Vanita Noronha, Nandini Menon et al. · Journal of Clinical Oncology · 2022 · 181 citations